Banerjee, R.N. , Kumar, V., Sahni , A.L., et al.: Antithrombin III deficiency in maturity onset diabetes mellitus and atherosclerosis. Thromb. Diath. Haemorrh., 31: 153, 1974.
4.
Banerjee, R.N. , Kumar, V., Rao , S.R., et al.; Antifibrin action of phenoformin . Diabetologia, 11: 105-111, 1975.
5.
Haust, M., Daria, A.C., Wyllie, J.C., More, R.M., Atherogenesis and plasma constituents.Demonstration of fibrin in the white plaque by fluorescent antibody technique. Am. J. Pathol., 44: 255, 1965.
6.
Crawford, T. , Woolf, N.: Hyaline arteriosclerosis in the spleen: An immunohistochemical study. J. Pathol. Bacterol. , 79: 221, 1960.
7.
Davies, M.J. , Woolf, N., Carstairs G.: Immunohistochemical studies in diabetic glomerulosclerosis . J. Pathol. Bacteriol. , 92: 441, 1966.
8.
Farquahr, A. , MacDonald, M.K., Ireland , J.T.: The role of fibrin deposition in diabetic glomerulosclerosis: A light, electron and immunofluorescence microscopy study . J. Clin. Pathol., 25: 664, 1972.
9.
Goldblatt, H. : Experimental hypertension induced by renal ischemia. Bull. N. Y. Acad. Med., 14: 523, 1938.
10.
Daniels, E.G. , Hinman, J.W., Leach , B.E., et al.: Identification of prostaglandin E2 as the principal vasodepressor lipid of rabbit renal medulla . Nature, 215: 1298, 1967.
11.
Lee, J.B., Crowshaw, K., Takman, B.H., et al: The identification of prostaglandine E2 F2c and A 2 from rabbit kidney medulla. Biochem. J., 105: 1251, 1967.
12.
Crawshaw, K. , Mc. Giff, J.C., Strand , J.C., et al.: Prostaglandins in dogs' renal medulla . J. Pharm. Pharmacol., 22: 302, 1970.
13.
Muirhead, E.E. , Stirman, J.A., Johnes , F.: Renal autoexplanation and protection against renoprival hypertensive cardiovascular disease and hemolysis. J. Clin. Invest., 39: 266, 1960.
14.
Muirhead, E.E. , Brown, G.B., Germain , G.S., et al.: The renal medulla as an antihypertensive organ. J. Lab. Clin. Med., 76: 641, 1970.
15.
Muirhead, E.E. , Brooks, B., Pitcock , J.A., et al.: Role of renal medulla in the Sodium sensitive component of renoprival hypertension . Lab. Invest. , 27: 192, 1972.
16.
Muirhead, E.E. : Vasoactive and antihypertensive effects of prostaglandins and other renomedullary lipids, in The Prostaglandins: Pharmacological and Therapeutic Advances. Edited by M.F. Cuthbert, London, Heinemann , 1973.
17.
Gomez, D.M. : Evaluation of renal resistances with special reference to changes in essential hypertension. J. Clin. Invest. , 30: 1143, 1951.
18.
Ratnoff, O.D. , Menzie, C.: New methods of the determination of fibrinogen in small samples of plasma. J. Lab. Clin. Med. , 37: 316, 1951.
19.
Dacie, J.V., Lewis, S.M.: Practical Haematology. Fourth edition. 1968, p. 174. J & A Publishers. Churchill Ltd., London , England.
20.
Von Kaulla, E. , Von Kaulla, K.N.: Antithrombin III and disease . Am. J. Clin. Pathol., 48: 69, 1967.
21.
Takeda, Y.: Studies of the metabolism and distribution of fibrinogen in healthy men with autologous I125 labelled fibrinogen. J. Clin. Invest. , 45: 103, 1966.
22.
Salaman, J.R. : Use of radioactive fibrinogen for detecting rejection of human renal transplants. Br. Med. J., 2: 517-521, 1970.
23.
Nagus, D., Pinto, D.J., LeQuenze, D.P. et al.: I-125 Labelled Fibrinogen in the diagnosis of deep vein thrombosis and its correlation with phlebography-Brit. J. Surg.55: 835, 1968.
Lindquist, R.R., Guttman, R.D., Merrill , J.P.Renal transplantation in the inbred rat. II. An immunohistochemical study of acute allograft rejection . Am. J. Pathol., 52: 531, 1968.
31.
McKenzie, I.F.R. , Whittingham, S.: Deposits of immunoglobulin and fibrin in human allografted kidneys. Lancet, 2: 1313, 1968.
32.
Salaman, J.R. : A technique for detecting rejection episodes in human transplant recipients using radioactive fibrinogen. Br. J. Surg., 59: 138-142, 1972.
33.
Yeboah, E.D. , Chisholm, G.D., Short , M.D., et al.: The detection and production of acute rejection episodes in human renal transplants using radioactive fibrinogen. Br. J. Urology, 45: 273-280, 1973.